Summary
95.71 -1.85(-1.90%)09/06/2024
BWX Technologies Inc (BWXT)
BWX Technologies Inc (BWXT)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -1.90 | -7.08 | 2.61 | 6.88 | -9.37 | 32.89 | 69.82 | 562.35 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 95.71 | |
| Open | 97.56 | |
| High | 97.94 | |
| Low | 95.70 | |
| Volume | 281,556 | |
| Change | -1.85 | |
| Change % | -1.90 | |
| Avg Volume (20 Days) | 276,902 | |
| Volume/Avg Volume (20 Days) Ratio | 1.02 | |
| 52 Week Range | 71.55 - 107.18 | |
| Price vs 52 Week High | -10.70% | |
| Price vs 52 Week Low | 33.77% | |
| Range | -1.90 | |
| Gap Up/Down | -1.55 | |
Fundamentals | ||
| Market Capitalization (Mln) | 8,753 | |
| EBIDTA | 397,111,008 | |
| PE Ratio | 32.5725 | |
| PEG Ratio | 2.3100 | |
| WallStreet Target Price | 101.89 | |
| Book Value | 10.3520 | |
| Earnings Per Share | 2.7600 | |
| EPS Estimate Current Quarter | 0.6900 | |
| EPS Estimate Next Quarter | 0.7300 | |
| EPS Estimate Current Year | 3.1700 | |
| EPS Estimate Next Year | 3.4000 | |
| Diluted EPS (TTM) | 2.7600 | |
| Revenues | ||
| Profit Marging | 0.1000 | |
| Operating Marging (TTM) | 0.1371 | |
| Return on asset (TTM) | 0.0723 | |
| Return on equity (TTM) | 0.2928 | |
| Revenue TTM | 2,531,915,008 | |
| Revenue per share TTM | 27.6310 | |
| Quarterly Revenue Growth (YOY) | 0.0630 | |
| Quarterly Earnings Growth (YOY) | 0.1200 | |
| Gross Profit (TTM) | 551,935,000 | |
| Dividends | ||
| Dividend Share | 0.9300 | |
| Dividend Yield | 0.0107 | |
| Valuations | ||
| Trailing PE | 32.5725 | |
| Forward PE | 21.7865 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 9.2607 | |
| Revenue Enterprise Value | 3.9167 | |
| EBITDA Enterprise Value | 21.8732 | |
| Shares | ||
| Shares Outstanding | 91,408,800 | |
| Shares Float | 90,949,003 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.01 | |
| Insider (%) | 0.37 | |
| Institutions (%) | 94.89 | |
09/05 11:59 EST - seekingalpha.com
BWX Technologies Trending Upward On Profitable Growth
BWX Technologies, Inc. (BWXT) is experiencing a renaissance with three consecutive quarters of higher earnings and more ahead. BWXT's competitive advantages include specialized technical capabilities, intellectual property, and a strong backlog, making it a growth candidate for green portfolios. Despite being overvalued, BWXT's projected earnings growth and a one-year price target of $110.19 justify a Buy rating.
BWX Technologies Trending Upward On Profitable Growth
BWX Technologies, Inc. (BWXT) is experiencing a renaissance with three consecutive quarters of higher earnings and more ahead. BWXT's competitive advantages include specialized technical capabilities, intellectual property, and a strong backlog, making it a growth candidate for green portfolios. Despite being overvalued, BWXT's projected earnings growth and a one-year price target of $110.19 justify a Buy rating.
08/06 18:08 EST - fool.com
Why BWX Technologies Stock Lagged the Market Today
The nuclear engineering specialist published its second-quarter earnings. It showed growth in key fundamentals, and notched a double beat on analyst expectations.
Why BWX Technologies Stock Lagged the Market Today
The nuclear engineering specialist published its second-quarter earnings. It showed growth in key fundamentals, and notched a double beat on analyst expectations.
08/05 20:34 EST - seekingalpha.com
BWX Technologies, Inc. (BWXT) Q2 2024 Earnings Call Transcript
BWX Technologies, Inc. (NYSE:BWXT ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Chase Jacobson - Vice President of Investor Relations Rex Geveden - President and CEO Robb LeMasters - Senior Vice President and CFO Conference Call Participants Scott Deuschle - Deutsche Bank Rob Labick - CJS Securities Pete Skibitski - Alembic Global Peter Arment - Baird Josh Korn - Barclays Andre Madrid - BTIG Michael Ciarmoli - Truist Securities Ron Epstein - Bank of America Thomas Meric - Janney Montgomery Operator Ladies and gentlemen, welcome to the BWX Technologies Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
BWX Technologies, Inc. (BWXT) Q2 2024 Earnings Call Transcript
BWX Technologies, Inc. (NYSE:BWXT ) Q2 2024 Earnings Conference Call August 5, 2024 5:00 PM ET Company Participants Chase Jacobson - Vice President of Investor Relations Rex Geveden - President and CEO Robb LeMasters - Senior Vice President and CFO Conference Call Participants Scott Deuschle - Deutsche Bank Rob Labick - CJS Securities Pete Skibitski - Alembic Global Peter Arment - Baird Josh Korn - Barclays Andre Madrid - BTIG Michael Ciarmoli - Truist Securities Ron Epstein - Bank of America Thomas Meric - Janney Montgomery Operator Ladies and gentlemen, welcome to the BWX Technologies Second Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
08/05 19:05 EST - zacks.com
BWX Technologies (BWXT) Q2 Earnings and Revenues Surpass Estimates
BWX Technologies (BWXT) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.65 per share a year ago.
BWX Technologies (BWXT) Q2 Earnings and Revenues Surpass Estimates
BWX Technologies (BWXT) came out with quarterly earnings of $0.82 per share, beating the Zacks Consensus Estimate of $0.76 per share. This compares to earnings of $0.65 per share a year ago.
08/05 16:06 EST - businesswire.com
BWX Technologies Reports Second Quarter 2024 Results
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT #earnings--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2024 results. A reconciliation of non-GAAP results are detailed in Exhibit 1. “Second quarter results were ahead of our expectations driven by strong organic growth and crisp execution across our business lines,” said Rex. D Geveden. “Our solid year-to-date performance provides us the confidence to raise the lower end of our 2024 non-GAAP EPS guidance.” “In recent m.
BWX Technologies Reports Second Quarter 2024 Results
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT #earnings--BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported second quarter 2024 results. A reconciliation of non-GAAP results are detailed in Exhibit 1. “Second quarter results were ahead of our expectations driven by strong organic growth and crisp execution across our business lines,” said Rex. D Geveden. “Our solid year-to-date performance provides us the confidence to raise the lower end of our 2024 non-GAAP EPS guidance.” “In recent m.
07/29 11:06 EST - zacks.com
BWX Technologies (BWXT) Earnings Expected to Grow: Should You Buy?
BWX (BWXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BWX Technologies (BWXT) Earnings Expected to Grow: Should You Buy?
BWX (BWXT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
07/22 07:00 EST - businesswire.com
NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production
BELOIT, Wis. & OTTAWA, Ontario--(BUSINESS WIRE)--NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production.
NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production
BELOIT, Wis. & OTTAWA, Ontario--(BUSINESS WIRE)--NorthStar Medical Radioisotopes and BWXT Medical Sign Supply Agreement Supporting Actinium-225 Production.
07/22 06:45 EST - businesswire.com
BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production
OTTAWA, Ontario & BELOIT, Wis.--(BUSINESS WIRE)---- $BWXT--BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues. Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures,.
BWXT Medical and NorthStar Medical Radioisotopes Sign Supply Agreement Supporting Actinium-225 Production
OTTAWA, Ontario & BELOIT, Wis.--(BUSINESS WIRE)---- $BWXT--BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc. (NYSE: BWXT) and NorthStar Medical Radioisotopes, LLC (NorthStar) today announced that they have signed a Master Services Agreement (MSA), which will facilitate the production of actinium-225 (Ac-225), a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues. Medical isotopes are essential for a wide range of diagnostic and therapeutic procedures,.
07/18 07:30 EST - investorplace.com
The Next Big Winners: 3 Under-The-Radar Stocks With Strong Potential
Popular stocks tend to get overvalued quickly. This can be a double-edged sword.
The Next Big Winners: 3 Under-The-Radar Stocks With Strong Potential
Popular stocks tend to get overvalued quickly. This can be a double-edged sword.
07/10 13:11 EST - zacks.com
Will BWX (BWXT) Beat Estimates Again in Its Next Earnings Report?
BWX (BWXT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will BWX (BWXT) Beat Estimates Again in Its Next Earnings Report?
BWX (BWXT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
07/03 08:00 EST - forbes.com
Which Is A Better Defense Pick – Huntington Ingalls Stock Or BWX Technologies?
We believe that Huntington Ingalls Industries stock , a military shipbuilding company, is currently a better pick than its industry peer – BWX Technologies stock (NYSE: BWXT), a supplier of nuclear components and fuel. BWXT stock trades at a higher multiple of 3.4x sales, versus 0.9x revenues for HII.
Which Is A Better Defense Pick – Huntington Ingalls Stock Or BWX Technologies?
We believe that Huntington Ingalls Industries stock , a military shipbuilding company, is currently a better pick than its industry peer – BWX Technologies stock (NYSE: BWXT), a supplier of nuclear components and fuel. BWXT stock trades at a higher multiple of 3.4x sales, versus 0.9x revenues for HII.
07/02 09:40 EST - zacks.com
Is the Options Market Predicting a Spike in BWX Technologies (BWXT) Stock?
Investors need to pay close attention to BWX Technologies (BWXT) stock based on the movements in the options market lately.
Is the Options Market Predicting a Spike in BWX Technologies (BWXT) Stock?
Investors need to pay close attention to BWX Technologies (BWXT) stock based on the movements in the options market lately.
06/26 12:41 EST - investorplace.com
3 Stocks That Could Benefit From Bill Gates' Billion-Dollar Bet on Nuclear
Whatever public perception of nuclear energy may be, Bill Gates has decided it's a worthy pursuit for his newly formed TerraPower. The former tech billionaire turned philanthropist has been aggressively searching for ways to improve the world in the ways he deems fit.
3 Stocks That Could Benefit From Bill Gates' Billion-Dollar Bet on Nuclear
Whatever public perception of nuclear energy may be, Bill Gates has decided it's a worthy pursuit for his newly formed TerraPower. The former tech billionaire turned philanthropist has been aggressively searching for ways to improve the world in the ways he deems fit.
06/24 15:03 EST - seekingalpha.com
BWX Technologies: Here Is Why The Stock Tanked After Earnings
BWX Technologies, Inc. stock outperformed expectations, gaining 40% due to strength in aerospace, defense, and energy transition sectors. Stock tanked after earnings due to a delay in aircraft carrier procurement, impacting future revenue projections. The company saw revenue growth but EBITDA fell short, with guidance for single-digit revenue growth and improved free cash flow, leading to a Hold rating.
BWX Technologies: Here Is Why The Stock Tanked After Earnings
BWX Technologies, Inc. stock outperformed expectations, gaining 40% due to strength in aerospace, defense, and energy transition sectors. Stock tanked after earnings due to a delay in aircraft carrier procurement, impacting future revenue projections. The company saw revenue growth but EBITDA fell short, with guidance for single-digit revenue growth and improved free cash flow, leading to a Hold rating.
06/21 09:19 EST - stockmarket.com
What Stocks To Buy Today? 2 Uranium Stocks To Know
Uranium stocks to watch in the stock market today.
What Stocks To Buy Today? 2 Uranium Stocks To Know
Uranium stocks to watch in the stock market today.
06/17 16:30 EST - businesswire.com
BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT--BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming.
BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT--BWXT Awarded Phase Two of Microreactor Evaluation Contract for State of Wyoming.
06/14 10:49 EST - youtube.com
BWX Technologies ($BWXT) Led-JV Awarded $30 Billion Operating Contract for Pantex Nuclear Plant
BWX Technologies (NYSE: BWXT), a provider of safe and effective nuclear solutions, has announced a contract award from the U.S. Department of Energy's National Nuclear Security Administration for managing and operating the Pantex Plant, located in Texas. The initial contract term is five years, with three additional five-year options, potentially totaling 20 years and approximately $30 billion.
BWX Technologies ($BWXT) Led-JV Awarded $30 Billion Operating Contract for Pantex Nuclear Plant
BWX Technologies (NYSE: BWXT), a provider of safe and effective nuclear solutions, has announced a contract award from the U.S. Department of Energy's National Nuclear Security Administration for managing and operating the Pantex Plant, located in Texas. The initial contract term is five years, with three additional five-year options, potentially totaling 20 years and approximately $30 billion.
06/14 09:00 EST - businesswire.com
BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT--BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant.
BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant
LYNCHBURG, Va.--(BUSINESS WIRE)---- $BWXT--BWXT-led Team Awarded $30 Billion Management and Operating Contract for National Nuclear Security Administration's Pantex Plant.
06/07 06:45 EST - businesswire.com
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration
OTTAWA, Ontario--(BUSINESS WIRE)---- $BWXT--BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration.
BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration
OTTAWA, Ontario--(BUSINESS WIRE)---- $BWXT--BWXT Medical Submits Drug Master File for Actinium-225 API to U.S. Food and Drug Administration.
05/07 12:25 EST - fool.com
Why BWX Technologies Stock Is Sinking Today
BWX topped first-quarter estimates, but the full-year guidance is a bit weak relative to expectations. The company also warned of delays in procuring the next Navy aircraft carrier.
Why BWX Technologies Stock Is Sinking Today
BWX topped first-quarter estimates, but the full-year guidance is a bit weak relative to expectations. The company also warned of delays in procuring the next Navy aircraft carrier.